Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elicio Therapeutics (ELTX) Change in Account Payables (2020 - 2026)

Elicio Therapeutics filings provide 4 years of Change in Account Payables readings, the most recent being -$40000.0 for Q4 2023.

  • On a quarterly basis, Change in Account Payables rose 85.82% to -$40000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $23000.0, a 97.96% decrease, with the full-year FY2025 number at -$366000.0, up 89.01% from a year prior.
  • Change in Account Payables hit -$40000.0 in Q4 2023 for Elicio Therapeutics, down from $142000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $4.4 million in Q2 2020 to a low of -$12.3 million in Q3 2020.
  • Median Change in Account Payables over the past 4 years was $51000.0 (2023), compared with a mean of -$332812.5.
  • Biggest five-year swings in Change in Account Payables: plummeted 418.31% in 2021 and later skyrocketed 204.69% in 2023.
  • Elicio Therapeutics' Change in Account Payables stood at $923000.0 in 2020, then plummeted by 418.31% to -$2.9 million in 2021, then surged by 90.4% to -$282000.0 in 2022, then surged by 85.82% to -$40000.0 in 2023.
  • The last three reported values for Change in Account Payables were -$40000.0 (Q4 2023), $142000.0 (Q3 2023), and -$1.5 million (Q2 2023) per Business Quant data.